This mutual regulation presents a paradox that androgen pathway inhibition and its consequential UGT2B17 upregulation should, theoretically, eliminate androgens completely in PCa cells, leading to irreversible tumor suppression and no CRPC progression, if the tumors rely on androgens to progress. The gene discussed is UGT2B17; the disease is posterior cortical atrophy.